-
Mashup Score: 7Blood Cancers Today - 13 hour(s) ago
Translating Hematologic Oncology Discoveries into Practice. Blood Cancers Today is a new publication that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings. Blood Cancers Today was developed to reach all professionals in the hematology/oncology universe, covering the latest news and analysis in leukemia, lymphoma, myeloma, myeloproliferative neoplasms, and other hematologic malignancies.
Source: www.youtube.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 10Meeting News | Blood Cancers Today - 18 hour(s) ago
The online home of the latest conference coverage and meeting news for hematologic oncologists. View the latest news on Blood Cancers Today.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 3Liso-Cel ‘Favorable’ Safety Profile in Second-line Follicular Lymphoma | Blood Cancers Today - 21 hour(s) ago
At a median follow-up of 18.1 months, the ORR and CR rates were both 95.7% following liso-cel treatment.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3
Drs. Lonial, Nabhan, and Stewart discussed the plenary session at ASH 2023, the PERSEUS trial, and treating smoldering MM.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 6The HemOnc Pulse Live | Blood Cancers Today - 2 day(s) ago
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
👏 We're only a few days away from #HOPLive24! 🎙️ Whether you're looking forward to the #bispecifics panel with @Rfonsi1, @mrbishop_UC_BMT, & @AaronGoodman33, or the #AML panel with @Daver_Leukemia & @MikkaelSekeres, there's lots in store! 🙌 Learn more: https://t.co/MydFt6GkqD https://t.co/3BeiSNz1vO
-
-
Mashup Score: 1SIMPLIFY-1: Momelotinib Leads to Higher Transfusion Independence in MF | Blood Cancers Today - 3 day(s) ago
Momelotinib achieved higher rates of transfusion independence compared with ruxolitinib.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Epcoritamab Produces Promising Responses in Patients With Follicular Lymphoma | Blood Cancers Today - 3 day(s) ago
Subcutaneous epcoritamab monotherapy yielded deep responses with promising response rates in high-risk relapsed or refractory follicular lymphoma.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3Molly Stoddart, RN, BSN, on Clinical Research Nursing in Multiple Myeloma | Blood Cancers Today - 3 day(s) ago
Molly Stoddart, RN, BSN, a clinical research nurse on the multiple myeloma team at the Winship Cancer Institute at Emory, shares her experiences.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 24Subscribe | Blood Cancers Today - 4 day(s) ago
Sign up for Blood Cancers Today eNewsletters to join an extensive community of hematologic oncology professionals and get the latest news and insights from the field.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 7Mosunetuzumab Continually Shows Safety, Efficacy in Relapsed or Refractory Follicular Lymphoma | Blood Cancers Today - 4 day(s) ago
Intravenous mosunetuzumab was administered in 21-day cycles, with step-up dosing integrated in cycle one.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
Are you subscribed to our YouTube channel yet? If not, you're missing out on tons of video interviews from hematologists like @SanjayPatelMD, @UjjaniC, @paurotero, and more! ☑️ Subscribe here: https://t.co/whO2sKw151 ☑️ Watch them on our website here: https://t.co/jvcKJQ9DD7 https://t.co/Xrai9lQ8HV